Xiidra is a lymphocyte function-associated antigen-1 (LFA-1)
antagonist, the fi rst medication in a new class of drugs.
1
Check it out at Xiidra-ECP.com
CHANGES
Well this
Reference: 1. FDA approves new medication for dry eye disease. FDA News Release. July 2016.
http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm510720.htm. Accessed July 12, 2016.
